Brainsway Announces Interim Results of an Animal Study of the Effects of Deep TMS on Macular Degeneration
JERUSALEM, Dec. 9, 2011 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received interim results from an animal study being conducted at the Sheba Medical Center to explore the effects of the Company's device on macular degeneration.